TissueTech Overview

  • Founded
  • 2001
Founded
  • Status
  • Private
  • Employees
  • 253
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 4

TissueTech General Information

Description

Developer of a medical technology platform designed to solve unmet clinical needs of birth-tissue regenerative medicine. The company's platform uses a tissue-processing method that preserves the innate biological and structural integrity of the natural placental tissue and delivers the anti-inflammatory, anti-scarring and anti-angiogenesis properties of that matrix, enabling healthcare professionals to deliver optimal patient healing outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
  • 7300 Corporate Center Drive
  • Suite 700
  • Miami, FL 33126
  • United States
+1 (786) 000-0000

TissueTech Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TissueTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC 24-May-2021 $15M 00000 Completed Profitable
16. Debt - PPP 13-Apr-2020 00.000 00000 Completed Profitable
15. Secondary Transaction - Private 30-Sep-2019 00000 Completed Profitable
14. Later Stage VC (Series C) 26-Jun-2019 000.00 00000 00000 Completed Profitable
13. Debt - General 09-Nov-2016 0000 Completed Profitable
12. Grant 01-Jan-2016 000 0000 Completed Profitable
11. Later Stage VC (Series B) 15-Jun-2015 0000 0000 00000 Completed Profitable
10. Debt - General 08-Jun-2015 0000 Completed Profitable
9. Debt - General 18-Mar-2015 $10M Completed Profitable
8. Grant 01-Jan-2015 $6.39M $10M Completed Profitable
To view TissueTech’s complete valuation and funding history, request access »

TissueTech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series B 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A 4,000,000 $0.001000 5% $6.9 $6.9 1x $6.9 17.26%
To view TissueTech’s complete cap table history, request access »

TissueTech Executive Team (13)

Name Title Board Seat Contact Info
Amy Tseng Co-Founder, President, Chief Executive Officer & Board Member
Michael Cornelius Chief Financial Officer
Tseng Scheffer Ph.D Co-Founder, Chief Technology Officer & Co-Chairman
Devin Buckley JD Chief Compliance Officer & Corporate Legal Counsel
Yiling Hsu Chief Information Officer
You’re viewing 5 of 13 executive team members. Get the full list »

TissueTech Board Members (11)

Name Representing Role Since
Amy Tseng TissueTech Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Brian Yeh Self Board Member 000 0000
Jane Hsiao Self Board Member 000 0000
John Arnott TissueTech Board Member 000 0000
Martin Sutter EW Healthcare Partners Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

TissueTech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TissueTech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EW Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Ballast Point Ventures Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view TissueTech’s complete investors history, request access »